Heartflow, Inc. (HTFL)
HTFLNASDAQ-GSMedical/Dental Instruments
$56.70
+0.0400 (+0.07%) today
At the close, Nov 10, 4:00 PM ET. After hours $60.51 +8.44%
- Market cap
- $4.85bn
- P/E
- –
- EPS, last 4 quarters
- $-0.9200
- Dividend yield
- –
- Day range
- $54.50 to $57.26
- 52-week range
- $20.13 to $60.56
- Average volume
- 1.77m
- Previous close
- $56.66
Analysts
8 coveringBuy7 buy, 1 hold, 0 sell
Targets a year out average $48.50, -14.5% from here
Earnings
next estimate $-0.1800Next report Nov 12, 2026
Sep 2025
-29.6%
Dec 2025
+25.0%
Mar 2026
+4.2%
Jun 2026
+27.3%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $46.27m | $49.13m | $52.59m | $64.08m |
| Gross profit | $35.41m | $39.06m | $42.16m | $53.19m |
| Operating income | -$15.10m | -$17.75m | -$29.50m | -$17.90m |
| Net income | -$50.85m | -$24.39m | -$27.38m | -$15.74m |
Last four quarters: revenue $212.07m, margin -55.8%, free cash flow -$59.18m
News
8 latest- iRhythm Holdings, Inc. (IRTC) Q3 Earnings Surpass EstimatesZacks · 5 days ago
- Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue EstimatesZacks · Oct 27, 2026
- Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5% RTTNews · Oct 6, 2026
- Biotech Stocks At 52-Week Highs - HSCS +7%, FRNM +5%, VOGX, HTFL, HALO RTTNews · Sep 21, 2026
- HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week HighThe Motley Fool · Sep 15, 2026
- UBS Initiates Coverage of HeartFlow at NeutralFintel · Sep 9, 2026
- HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week HighThe Motley Fool · Sep 6, 2026
- Heartflow FFRCT Cuts Unnecessary Invasive Heart Procedures 44% In FUSION Trial RTTNews · Aug 28, 2026
The company
Heartflow is transforming coronary artery disease from the world's leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow - all without invasive procedures. Discover how we're shaping the future of cardiovascular care at heartflow.com.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- heartflow.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.